Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C0XU
|
||||
| Former ID |
DNC011233
|
||||
| Drug Name |
N-n-heptyl-7-methoxytacrine hydrochloride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531150] | ||
| Formula |
C21H31ClN2O
|
||||
| Canonical SMILES |
CCCCCCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC.Cl
|
||||
| InChI |
1S/C21H30N2O.ClH/c1-3-4-5-6-9-14-22-21-17-10-7-8-11-19(17)23-20-13-12-16(24-2)15-18(20)21;/h12-13,15H,3-11,14H2,1-2H3,(H,22,23);1H
|
||||
| InChIKey |
FSGDAOFEXGDTBL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [531150] | |
| Cholinesterase | Target Info | Inhibitor | [531150] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||